This promotional material is intended for UK healthcare professionals (HCPs) experienced in the diagnosis and management of migraine only. Prescribing Information and adverse event reporting information can be found below.
.png){kind=logo}
Resources
For healthcare professionals
Getting Started with AQUIPTA®
To support with the initiation of AQUIPTA® for your eligible migraine patients, this leaflet provides guidance on selecting the right patients, considerations for selecting the correct dose, important details for your patient to understand before starting treatment and the next steps for their treatment journey.
To receive a copy of this leaflet, please submit your details on the Contact us page and tick Getting Started with AQUIPTA®.
For your patients
Patient booklet: My Treatment with AQUIPTA® in Migraine
To support your migraine patients treated with AQUIPTA®, this booklet provides guidance on what the medication is, how it works and important details to know while taking it.
This booklet includes a migraine diary designed to help patients keep track of their symptoms, possible triggers and medication(s) taken.
To receive a copy of this leaflet, please submit your details on the Contact us page and tick Patient booklet.
UK-AQP-250080 | Date of preparation: March 2025.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk
Adverse events should also be reported to AbbVie on GBPV@abbvie.com
